Field Medical announced today that it closed a Series B funding round worth proceeds totaling $35 million. BioStar Capital and Cue Growth led the round, which had participation from existing strategic investors, too. This funding adds to a $40 million Series A brought in earlier this year and brings the Cardiff-by-the-Sea, California-based … [Read more...] about Field Medical raises $35M Series B to support pulsed field ablation tech
Catheters
Acutus to sell electrophysiology assets to EnChannel
EnChannel Medical announced today that it agreed to acquire the AcQMap platform assets from Acutus Medical. This deal centers around the AcQMap high-resolution imaging and mapping platform from Acutus. It also includes substantive intellectual property, quality and regulatory documentation and clinical data. With the agreement, EnChannel receives … [Read more...] about Acutus to sell electrophysiology assets to EnChannel
Teleflex completes acquisition of Biotronik’s Vascular Intervention business
Teleflex [WtwhTicker symbol="TFX"](NYSE: TFX)[/WtwhTicker] announced today that it completed its previously announced acquisition of the Biotronik Vascular Intervention (VI) business. As part of strategy shifts by both companies, Teleflex in February agreed to acquire substantially all of the Biotronik VI unit. The acquisition adds a broad … [Read more...] about Teleflex completes acquisition of Biotronik’s Vascular Intervention business
InterShunt enrolls first patient in heart failure treatment study
InterShunt Technologies announced today that it has begun an early feasibility study of its device for reducing symptoms of heart failure. Dr. Sitaramesh Emani and the Structural Heart Intervention Team at The Christ Hospital Health Network in Cincinnati, performed the first procedure utilizing the technology. The study focuses on patients with … [Read more...] about InterShunt enrolls first patient in heart failure treatment study
Circa completes limited launch of transseptal access system
Circa Scientific announced that it completed the limited market release for its CrossWise RF transseptal access system. Englewood, Colorado-based Circa designed its zero-exchange RF system to deliver energy through a purpose-built cannula. The cannula maintains shape and stability during septal crossing. This approach allows for deliberate control … [Read more...] about Circa completes limited launch of transseptal access system
Cook Medical angiographic catheter recall is Class I
The FDA has designated Cook Medical's recall of its Beacon Tip 5.0 Fr angiographic catheter as Class I, the most serious level. Users reported tip separation occurring both before and during patient contact, according to an FDA notice published today. As a result, catheter fragmentation and embolization might occur with the catheters involved in … [Read more...] about Cook Medical angiographic catheter recall is Class I
Anaconda Biomed wins CE mark for funnel catheter
Anaconda Biomed announced today that it received CE mark approval to commercialize its ANA5 funnel catheter in Europe. The company designed ANA5, a next-generation funnel catheter, to optimize mechanical thrombectomy. It maximizes clot capture with its vessel-matching diameter funnel. Simultaneously, it enables antegrade flow arrest and offers the … [Read more...] about Anaconda Biomed wins CE mark for funnel catheter
FDA adds Gradient denervation tech to advisory program
Gradient Denervation Technologies announced today that the FDA accepted it into its Total Product Life Cycle Advisory Program (TAP). TAP provides early and frequent strategic engagement from the FDA, patients, providers and payers. It facilitates rapid development and widespread access to medical devices. The company expects its acceptance into … [Read more...] about FDA adds Gradient denervation tech to advisory program
Penumbra completes enrollment in pulmonary embolism trial
Penumbra (NYSE:PEN) announced today that it completed enrollment in the STORM-PE trial of its Lightning Flash system. STORM-PE evaluates Lightning Flash computer-assisted vacuum thrombectomy (CAVT) plus anticoagulation. It pits that against anticoagulation alone in the treatment of acute intermediate-high risk pulmonary embolism (PE). The study … [Read more...] about Penumbra completes enrollment in pulmonary embolism trial
Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
Philips today announced the first procedures in Europe with its recently launched VeriSight Pro 3D ICE catheter. Doctors at the German University Medical Center Mainz and Robert Bosch Hospital in Stuttgart completed the first procedures in Europe after the intracardiac echocardiography (ICE) catheter following its launch across the continent last … [Read more...] about Philips reports first cases for VeriSight Pro 3D ICE catheter in Europe
